Show simple item record

Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal

dc.contributor.authorKadioglu, Teoman Cem
dc.date.accessioned2021-03-04T12:45:27Z
dc.date.available2021-03-04T12:45:27Z
dc.date.issued2009
dc.identifier.citationKadioglu T. C. , "Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal", INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.41, sa.4, ss.773-776, 2009
dc.identifier.issn0301-1623
dc.identifier.otherav_78eb4ce8-369c-421b-868f-1bd1e1e6e2e2
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/82916
dc.identifier.urihttps://doi.org/10.1007/s11255-009-9568-3
dc.description.abstractTo identify a subgroup of normogonadotropic men who may benefit relatively more from TC (tamoxifen citrate; a widely prescribed drug for male infertility) among those with FSH (follicle-stimulating hormone) values in the lower or higher halves of the normal range.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleOral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal
dc.typeMakale
dc.relation.journalINTERNATIONAL UROLOGY AND NEPHROLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Üroloji
dc.identifier.volume41
dc.identifier.issue4
dc.identifier.startpage773
dc.identifier.endpage776
dc.contributor.firstauthorID32871


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record